T&L Co., Ltd. (KOSDAQ:340570)

Market Cap	464.19B -19.0%
Revenue (ttm)	157.91B -21.6%
Net Income	38.66B -29.9%
EPS	4,806.69 -29.7%
Shares Out	8.02M
PE Ratio	12.05
Forward PE	7.48
Dividend	1,500.00 (2.92%)
Ex-Dividend Date	Dec 29, 2025

Volume	81,195
Open	53,400
Previous Close	51,300
Day's Range	53,000 - 59,100
52-Week Range	43,100 - 68,000
Beta	0.36
Analysts	Strong Buy
Price Target	89,000.00 (+53.71%)
Earnings Date	May 28, 2026

About T&L Co., Ltd.

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 242
• Stock Exchange: KOSDAQ
• Ticker Symbol: 340570

Financial Performance

In 2025, T&L Co., Ltd.'s revenue was 164.16 billion, a decrease of -6.14% compared to the previous year's 174.89 billion. Earnings were 38.07 billion, a decrease of -17.96%.

Analyst Summary

According to 2 analysts, the average rating for 340570 stock is "Strong Buy." The 12-month stock price target is ₩89,000, which is an increase of 53.71% from the latest price.

Price Target

₩89,000

(53.71% upside)

Analyst Consensus: Strong Buy